These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11679467)

  • 1. Remission of nephrotic-range albuminuria in type 1 diabetic patients.
    Hovind P; Rossing P; Tarnow L; Toft H; Parving J; Parving HH
    Diabetes Care; 2001 Nov; 24(11):1972-7. PubMed ID: 11679467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved survival in patients obtaining remission of nephrotic range albuminuria in diabetic nephropathy.
    Hovind P; Tarnow L; Rossing P; Carstensen B; Parving HH
    Kidney Int; 2004 Sep; 66(3):1180-6. PubMed ID: 15327415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Jul; 60(1):277-83. PubMed ID: 11422762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smoking and progression of diabetic nephropathy in type 1 diabetes.
    Hovind P; Rossing P; Tarnow L; Parving HH
    Diabetes Care; 2003 Mar; 26(3):911-6. PubMed ID: 12610058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.
    Rossing K; Christensen PK; Hovind P; Parving HH
    Diabetologia; 2005 Nov; 48(11):2241-7. PubMed ID: 16170513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.
    Parving HH; Hommel E; Jensen BR; Hansen HP
    Kidney Int; 2001 Jul; 60(1):228-34. PubMed ID: 11422755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stable glomerular filtration rate in normotensive IDDM patients with stable microalbuminuria. A 5-year prospective study.
    Mathiesen ER; Feldt-Rasmussen B; Hommel E; Deckert T; Parving HH
    Diabetes Care; 1997 Mar; 20(3):286-9. PubMed ID: 9051373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Course of glomerular filtration rate in albuminuric type 2 diabetic patients with or without diabetic glomerulopathy.
    Christensen PK; Gall MA; Parving HH
    Diabetes Care; 2000 Apr; 23 Suppl 2():B14-20. PubMed ID: 10860186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
    Haraguchi K; Hara S; Ubara Y; Tanaka S; Nukui I; Shimura H; Ohashi K; Kobayashi T
    Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences between nisoldipine and lisinopril on glomerular filtration rates and albuminuria in hypertensive IDDM patients with diabetic nephropathy during the first year of treatment.
    Rossing P; Tarnow L; Boelskifte S; Jensen BR; Nielsen FS; Parving HH
    Diabetes; 1997 Mar; 46(3):481-7. PubMed ID: 9032106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuric renal disease in type 2 diabetes-is remission of proteinuria associated with improved mortality and morbidity?
    Tan J; Jaung R; Gamble G; Cundy T
    Diabetes Res Clin Pract; 2014 Jan; 103(1):63-70. PubMed ID: 24380605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fish oil in diabetic nephropathy.
    Rossing P; Hansen BV; Nielsen FS; Myrup B; Hølmer G; Parving HH
    Diabetes Care; 1996 Nov; 19(11):1214-9. PubMed ID: 8908382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PC-1 amino acid variant (K121Q) has no impact on progression of diabetic nephropathy in type 1 diabetic patients.
    Jacobsen P; Grarup N; Tarnow L; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2002 Aug; 17(8):1408-12. PubMed ID: 12147787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of diabetic nephropathy.
    Hovind P; Rossing P; Tarnow L; Smidt UM; Parving HH
    Kidney Int; 2001 Feb; 59(2):702-9. PubMed ID: 11168952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancy and progression of diabetic nephropathy.
    Rossing K; Jacobsen P; Hommel E; Mathiesen E; Svenningsen A; Rossing P; Parving HH
    Diabetologia; 2002 Jan; 45(1):36-41. PubMed ID: 11845221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria.
    Gaede P; Tarnow L; Vedel P; Parving HH; Pedersen O
    Nephrol Dial Transplant; 2004 Nov; 19(11):2784-8. PubMed ID: 15328385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural course of kidney function in Type 2 diabetic patients with diabetic nephropathy.
    Christensen PK; Rossing P; Nielsen FS; Parving HH
    Diabet Med; 1999 May; 16(5):388-94. PubMed ID: 10342338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remission and regression of diabetic nephropathy.
    Hovind P; Tarnow L; Parving HH
    Curr Hypertens Rep; 2004 Oct; 6(5):377-82. PubMed ID: 15341691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment.
    Rossing P; Hommel E; Smidt UM; Parving HH
    Diabetologia; 1994 May; 37(5):511-6. PubMed ID: 8056190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The course of kidney function in type 2 (non-insulin-dependent) diabetic patients with diabetic nephropathy.
    Gall MA; Nielsen FS; Smidt UM; Parving HH
    Diabetologia; 1993 Oct; 36(10):1071-8. PubMed ID: 8243857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.